Lite Strategy, Inc.
- LITS
- NASDAQ
- Biotechnology
- Oncology Therapeutics
- Clinical-Stage Biotech
$1.15
Today −3.77%Quote Oct 16, 2026, 08:00 PM UTC
+10.58%over the last month
Max drawdown −20.1%From 1-month high −20.1%3 months +11.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$35.0M
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.15
0.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LITSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
5